Bright Minds Biosciences (DRUG) Intangibles (2020 - 2022)

Bright Minds Biosciences has reported Intangibles for 3 years, with the latest figure at $1568.7 in Q2 2022.

• For the quarter ending Q2 2022, Intangibles fell 3.59% year-over-year to $1568.7; the trailing twelve-month figure through Jun 2022 stood at $1568.7 (down 3.59% YoY), and the FY2021 full-year result was $1588.8, up 5.86% from the prior year.
• Intangibles for Q2 2022 stood at $1568.7, down from $1579.0 in the prior quarter.
• The five-year high for Intangibles was $1627.1 in Q2 2021, with the low at $1500.8 in Q3 2020.
• Historically, Intangibles has averaged $1575.2 across 3 years, with a median of $1582.8 in 2021.
• Annual changes were most pronounced in 2021 — Intangibles grew 5.86% — and 2022, when it retreated 3.59%.
• Bright Minds Biosciences' Intangibles stood at $1500.8 in 2020, then advanced by 5.72% to $1586.7 in 2021, then retreated by 1.13% to $1568.7 in 2022.
• The last three Intangibles figures came in at $1568.7 (Q2 2022), $1579.0 (Q1 2022), and $1586.7 (Q4 2021), per Business Quant data.